IQVIA and NVIDIA Collaborate to Transform Healthcare Research with Advanced AI Models
IQVIA, a global leader in clinical research services and healthcare intelligence, has partnered with NVIDIA to develop customized foundation models and agentic AI workflows. This collaboration aims to revolutionize research and clinical development processes, ultimately enhancing access to new treatments. By harnessing the power of AI applications trained on comprehensive healthcare data and driven by deep domain expertise, IQVIA seeks to enhance the efficiency of clinical trials, optimize therapy and medical device launches, and improve patient outcomes.
Operating across more than 100 countries, IQVIA has established the largest global healthcare network, offering unparalleled access to a vast and intricate set of information, analytics, and technologies. This unique position allows IQVIA to connect with the healthcare ecosystem in ways that few others can match.
The announcement of this collaboration was made at the J.P. Morgan Conference in San Francisco. IQVIA’s suite of models, AI agents, and reference workflows will be developed using the NVIDIA AI Foundry platform, which specializes in building custom models. This will enable IQVIA’s extensive range of pharmaceutical, biotech, and medical device customers to benefit from NVIDIA’s agentic AI capabilities, combined with IQVIA’s industry-leading technologies and expertise in life sciences.
Enabling Industry Applications in Clinical Trials
The healthcare and life sciences sector is responsible for generating an enormous volume of information, accounting for 30% of the world’s data. The collaboration between IQVIA and NVIDIA aims to leverage IQVIA’s unmatched information assets, analytics, and domain expertise—collectively known as IQVIA Connected Intelligence—using the NVIDIA AI Foundry service to create language and multimodal foundational models. These models will support a collection of customized IQVIA AI agents, designed to perform specific tasks within predefined workflows or blueprints.
This partnership is set to accelerate the innovation cycle of IQVIA Healthcare-grade AI. IQVIA has been a pioneer in the responsible use of AI, ensuring its AI-driven capabilities adhere to principles of privacy, regulatory compliance, and patient safety. IQVIA Healthcare-grade AI reflects the company’s dedication to these core values.
A significant opportunity lies in clinical development, particularly in the execution of clinical trials for new drugs. The entire process typically spans around 11 years, involving numerous workflows that could be enhanced by AI agents. For instance, initiating a clinical trial requires selecting sites, recruiting participants, submitting regulatory documents, and maintaining close communication between study sites and sponsors.
NVIDIA AI Foundry Streamlines Custom Model Development
To facilitate the creation of these AI agents, IQVIA is utilizing tools from the NVIDIA AI Foundry and the NVIDIA AI Enterprise software platform. This includes NVIDIA NIM microservices, especially the Llama Nemotron and Cosmos Nemotron model families, and NVIDIA AI Blueprint reference workflows. Additionally, the NVIDIA NeMo platform enables the development of custom generative AI, with dedicated capacity available on the NVIDIA DGX Cloud.
The NVIDIA AI Blueprint for multimodal PDF data extraction will assist IQVIA in unlocking vast amounts of healthcare text, graphs, charts, and tables stored in PDF files. This process brings previously inaccessible information to the forefront, allowing AI models and agents to be trained for domain-specific and customer-specific applications. NVIDIA RAPIDS data science libraries further expedite the construction of knowledge graphs.
Moreover, AI agents can automate complex, time-consuming tasks such as document generation and patient recruitment. This automation allows healthcare professionals to concentrate on strategic decision-making and human interaction, thereby enhancing the overall efficiency and effectiveness of healthcare services.
For those interested in exploring further, additional information about NVIDIA technologies and their impact on healthcare and life sciences is available on NVIDIA’s blog.
This collaboration between IQVIA and NVIDIA represents a significant advancement in healthcare research and development. By combining cutting-edge AI technology with extensive healthcare data and expertise, the partnership aims to streamline processes, reduce timelines, and ultimately improve patient care. As AI continues to evolve, its integration into healthcare will likely lead to groundbreaking innovations and more efficient, effective treatments for patients worldwide.
For more Information, Refer to this article.
